glp-1 for crohn's Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology Ozempic and Crohn's Disease: Could
Description
Some European countries have more room within their budgets to provide such coverage than others
Thus, gut microbiota is a promising strategy for improving obesity and related metabolic disorders
Some economists even speculate that widespread GLP-1 use could have macroeconomic benefits by improving population health (e.g., a Goldman Sachs report posited that reducing obesity via GLP-1 drugs might increase labor productivity and reduce healthcare expenditure long-term) ( [151] )
Cells 2019 , 8 , 589
